Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial

R. Lesurf, O. L. Griffith, M. Griffith, J. Hundal, L. Trani, M. A. Watson, R. Aft, M. J. Ellis, D. Ota, V. J. Suman, F. Meric-Bernstam, A. M. Leitch, J. C. Boughey, G. Unzeitig, A. U. Buzdar, K. K. Hunt, E. R. Mardis

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences